litlas
Log inCreate account

Scott M. Hammer

Active 1982–2020

Also published as
SCOTT M. HAMMER
62
Papers
20,694
Citations
58
h-index
61
i10-index

Citations

Citations per year for Scott M. Hammer1983: 3 citations1984: 4 citations1985: 5 citations1986: 7 citations1987: 14 citations1988: 18 citations1989: 21 citations1990: 15 citations1991: 11 citations1992: 14 citations1993: 7 citations1994: 13 citations1995: 6 citations1996: 13 citations1997: 49 citations1998: 194 citations1999: 221 citations2000: 257 citations2001: 177 citations2002: 178 citations2003: 178 citations2004: 170 citations2005: 142 citations2006: 119 citations2007: 113 citations2008: 174 citations2009: 268 citations2010: 195 citations2011: 191 citations2012: 158 citations2013: 139 citations2014: 114 citations2015: 74 citations2016: 76 citations2017: 38 citations2018: 51 citations2019: 169 citations2020: 171 citations2021: 154 citations2022: 108 citations2023: 54 citations2024: 111 citations2025: 53 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,012 citing papers, 37.6% of this breakdownUnited Kingdom: 372 citing papers, 6.9% of this breakdownCanada: 266 citing papers, 5% of this breakdownFrance: 240 citing papers, 4.5% of this breakdownSpain: 191 citing papers, 3.6% of this breakdownSwitzerland: 175 citing papers, 3.3% of this breakdownItaly: 171 citing papers, 3.2% of this breakdownGermany: 169 citing papers, 3.2% of this breakdownSouth Africa: 155 citing papers, 2.9% of this breakdownNetherlands: 148 citing papers, 2.8% of this breakdownChina: 122 citing papers, 2.3% of this breakdownAustralia: 114 citing papers, 2.1% of this breakdown
0%37.6%Other 22.6%

Institutions

Fields

  • Medicine60.3%
  • Immunology and Microbiology25.6%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Mathematics2.5%
  • Computer Science1.8%
  • Health Professions1%
  • Other3.9%

Topics

  • HIV Research and Treatment18%
  • HIV/AIDS drug development and treatment15.4%
  • HIV/AIDS Research and Interventions14%
  • HIV-related health complications and treatments6.5%
  • Immune Cell Function and Interaction1.7%
  • Cytomegalovirus and herpesvirus research1.5%
  • Other42.9%

Coauthors

All papers

Open in search
  1. A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Authors: Scott M. Hammer, David Katzenstein, Michael D. Hughes, Holly Gundacker, Robert T. Schooley, Richard Haubrich, W. Keith Henry, Michael M. Lederman, John Phair, Manette T. Niu, Martin Hirsch, Thomas C. Merigan - New England Journal of Medicine 1996 cited by 1,102

  2. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Authors: Scott M. Hammer, Magdalena E. Sobieszczyk, Holly Janes, Shelly Karuna, Mark J. Mulligan, Doug Grove, Beryl A. Koblin, Susan Buchbinder, Michael C. Keefer, Georgia D. Tomaras, Nicole Frahm, John Hural, Chuka Anude, Barney S. Graham, Mary E. Enama, Elizabeth M. Adams, Edwin DeJesus, Richard Novák, Ian Frank, Carter Bentley, Shelly Ramirez, Rong Fu, Richard A. Koup, John R. Mascola, Gary J. Nabel, David C. Montefiori, James G. Kublin, M. Juliana McElrath, Lawrence Corey, Peter B. Gilbert - New England Journal of Medicine 2013 cited by 585

  3. The Challenge of HIV-1 Subtype Diversity

    Authors: Barbara S. Taylor, Magdalena E. Sobieszczyk, Francine E. McCutchan, Scott M. Hammer - New England Journal of Medicine 2008 cited by 626

  4. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

    Authors: Scott M. Hammer, Kathleen Squires, Michael D. Hughes, Janet M. Grimes, Lisa M. Demeter, Judith S. Currier, Joseph J. Eron, Judith Feinberg, Henry H. Balfour, Lawrence Deyton, Jeffrey Chodakewitz, Margaret A. Fischl, John Phair, Louise Pedneault, Bach‐Yen Nguyen, Jon C. Cook - New England Journal of Medicine 1997 cited by 2,672

  5. Antiretroviral Treatment of Adult HIV Infection

    Authors: Melanie Thompson, Judith A. Aberg, Jennifer F. Hoy, Amalio Telenti, Constance Benson, Pedro Cahn, Joseph J. Eron, Huldrych F. Günthard, Scott M. Hammer, Peter Reiss, Douglas D. Richman, Giuliano Rizzardini, David L. Thomas, Donna M. Jacobsen, Paul A. Volberding - JAMA 2012 cited by 2,477

  6. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

    Authors: Scott D. Neidich, Youyi Fong, Shuying S. Li, Daniel E. Geraghty, Brian D. Williamson, William C. Young, Derrick Goodman, Kelly E. Seaton, Xiaoying Shen, Sheetal Sawant, Lu Zhang, Allan C. deCamp, Bryan S. Blette, Mengshu Shao, Nicole L. Yates, Frederick Feely, Chul‐Woo Pyo, Guido Ferrari, Ian Frank, Shelly Karuna, Edith Swann, John R. Mascola, Barney S. Graham, Scott M. Hammer, Magdalena E. Sobieszczyk, Lawrence Corey, Holly Janes, M. Juliana McElrath, Raphaël Gottardo, Peter B. Gilbert, Georgia D. Tomaras - Journal of Clinical Investigation 2019 cited by 123

  7. Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

    Authors: Holly Janes, Kristen W. Cohen, Nicole Frahm, Stephen C. De Rosa, Brittany Sanchez, John Hural, Craig A. Magaret, Shelly Karuna, Carter Bentley, Raphaël Gottardo, Greg Finak, Douglas I. Grove, Mingchao Shen, Barney S. Graham, Richard A. Koup, Mark J. Mulligan, Beryl A. Koblin, Susan Buchbinder, Michael C. Keefer, Elizabeth M. Adams, Chuka Anude, Lawrence Corey, Magdalena E. Sobieszczyk, Scott M. Hammer, Peter B. Gilbert, M. Juliana McElrath - The Journal of Infectious Diseases 2017 cited by 75

  8. 207-nm UV Light - A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. I: In Vitro Studies

    Authors: Manuela Buonanno, Gerhard Randers-Pehrson, Alan W. Bigelow, Sheetal Trivedi, Franklin D. Lowy, Henry M. Spotnitz, Scott M. Hammer, David J. Brenner - PLoS ONE 2013 cited by 177

  9. Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence

    Authors: Brett Hanscom, Holly Janes, Peter Guarino, Ying Huang, Elizabeth R. Brown, Ying Qing Chen, Scott M. Hammer, Peter B. Gilbert, Deborah Donnell - JAIDS Journal of Acquired Immune Deficiency Syndromes 2016 cited by 94

  10. Antiretroviral Treatment of Adult HIV Infection

    Authors: Melanie Thompson, Judith A. Aberg, Pedro Cahn, Joan Montaner, Giuliano Rizzardini, Amalio Telenti, José M. Gatell, Huldrych F. Günthard, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, Peter Reiss, Douglas D. Richman, Paul A. Volberding, Patrick Yéni, Robert T. Schooley - JAMA 2010 cited by 725

  11. The Challenge of HIV-1 Subtype Diversity

    Authors: Barbara S. Taylor, Scott M. Hammer - New England Journal of Medicine 2008 cited by 133

  12. Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

    Authors: Paul Goepfert, Marnie Elizaga, Kelly E. Seaton, Georgia D. Tomaras, David C. Montefiori, Alicia Sato, John Hural, Stephen C. DeRosa, Spyros A. Kalams, M. Juliana McElrath, Michael C. Keefer, Lindsey R. Baden, Javier R. Lama, Jorge Sánchez, Mark J. Mulligan, Susan Buchbinder, Scott M. Hammer, Beryl A. Koblin, Michael Pensiero, Christopher Butler, Bernard Moss, Harriet L. Robinson - The Journal of Infectious Diseases 2014 cited by 84

  13. Activation of Human Immunodeficiency Virus by Herpes Simplex Virus

    Authors: M P Golden, Steven Kim, Scott M. Hammer, E. A. Ladd, P A Schaffer, Nickolas DeLuca, Mary Albrecht - The Journal of Infectious Diseases 1992 cited by 124

  14. Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel

    Authors: Martin S. Hirsch, Huldrych F. Günthard, Jonathan Schapiro, Françoise Brun‐Vézinet, Bonaventura Clotet, Scott M. Hammer, Victoria A. Johnson, Daniel R. Kuritzkes, John W. Mellors, Deenan Pillay, Patrick Yéni, Donna M. Jacobsen, Douglas D. Richman - Clinical Infectious Diseases 2008 cited by 573

  15. Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries

    Authors: Aileen Y. Chang, Maria E Parrales, Javier Castro-Jiménez, Magdalena E. Sobieszczyk, Scott M. Hammer, David Copenhaver, Rajan P. Kulkarni - International Journal of Health Geographics 2009 cited by 183

  16. Zidovudine: Five Years Later

    Authors: Gavin X. McLeod, Scott M. Hammer - Annals of Internal Medicine 1992 cited by 158

  17. Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials

    Authors: Peter B. Gilbert, James O. Berger, Donald M. Stablein, Simone Becker, Max Essex, Scott M. Hammer, J. H. Kim, Victor G. DeGruttola - The Journal of Infectious Diseases 2011 cited by 99

  18. Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected Women

    Authors: Michael T. Yin, Don McMahon, David C. Ferris, Chiyuan A. Zhang, Aimee Shu, Ronald B. Staron, Ivelisse Colón, Jeffrey Laurence, Jay F. Dobkin, Scott M. Hammer, Elizabeth Shane - The Journal of Clinical Endocrinology & Metabolism 2009 cited by 88

  19. Treatment for Adult HIV Infection

    Authors: Patrick Yéni, Scott M. Hammer, Martin Hirsch, Michael S. Saag, Mauro Schechter, Charles C. J. Carpenter, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Donna M. Jacobsen, David Katzenstein, Joan Montaner, Douglas D. Richman, Robert T. Schooley, Melanie Thompson, Stefano Vella, Paul A. Volberding - JAMA 2004 cited by 1,037

  20. Antiretroviral Therapy for HIV Infection in 1998

    Authors: Charles C. J. Carpenter, Margaret A. Fischl, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, David Katzenstein, Julio Montaner, Douglas D. Richman, Michael S. Saag, Robert T. Schooley, Melanie Thompson, Stefano Vella, Patrick Yéni, Paul A. Volberding - JAMA 1998 cited by 1,016

  21. Antiretroviral Treatment for Adult HIV Infection in 2002

    Authors: Patrick Yéni, Scott M. Hammer, Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Martin Hirsch, Donna M. Jacobsen, David Katzenstein, Julio Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie Thompson, Stefano Vella, Paul A. Volberding - JAMA 2002 cited by 713

  22. The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

    Authors: David Katzenstein, Scott M. Hammer, Michael D. Hughes, Holly Gundacker, J. Brooks Jackson, Susan A. Fiscus, Suraiya Rasheed, Tarek Elbeik, Richard C. Reichman, Anthony J. Japour, Thomas C. Merigan, Martin Hirsch - New England Journal of Medicine 1996 cited by 485

  23. Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

    Authors: Ian C. Marschner, Ann C. Collier, Robert W. Coombs, Richard T. D’Aquila, Victor DeGruttola, Margaret A. Fischl, Scott M. Hammer, Michael D. Hughes, Victoria A. Johnson, David Katzenstein, Douglas D. Richman, Laura Smeaton, Stephen A. Spector, Michael S. Saag - The Journal of Infectious Diseases 1998 cited by 249

  24. Staphylococcus epidermidis Infections

    Authors: Franklin D. Lowy, SCOTT M. HAMMER - Annals of Internal Medicine 1983 cited by 213